Elizabeth Balta - 21 Sep 2021 Form 3 Insider Report for Icosavax, Inc.

Role
General Counsel and Corporate Secretary Exhibit List: Exhibit 24 - Power of Attorney
Signature
/s/ Elizabeth Bekiroglu
Issuer symbol
N/A
Transactions as of
21 Sep 2021
Net transactions value
$0
Form type
3
Filing time
21 Sep 2021, 21:48:57 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ICVX Common Stock 27,750 21 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICVX Stock Option (Right to Buy) 21 Sep 2021 Common Stock 222,250 $39.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on September 7, 2021, 25% of the total number of RSUs granted vest on each of the first four anniversaries of September 7, 2021, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate as provided in the reporting person's offer letter. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2 25% of the shares subject to the option will vest on 9/7/2022, and 1/48th of the shares subject to the option vest monthly thereafter.

Remarks:

General Counsel and Corporate Secretary Exhibit List: Exhibit 24 - Power of Attorney